Core Points - POMDOCTOR LIMITED has successfully closed its initial public offering (IPO) of 5,000,004 American Depositary Shares (ADSs) at a price of US$4.00 per ADS, raising approximately US$20.0 million in gross proceeds before expenses [1][2][3] Company Overview - POMDOCTOR LIMITED is a leading online medical services platform for chronic diseases in China, ranking sixth in the Internet hospital market based on contracted doctors in 2022 [5] - The company focuses on chronic disease management and pharmaceutical services, providing a one-stop platform that connects patients with doctors and pharmaceutical products [5] - POMDOCTOR aims to enhance the efficiency and transparency of the healthcare value chain, with a mission to provide effective prevention and treatment solutions for patients [5]
POMDOCTOR LIMITED Announces Closing of Initial Public Offering